Human cytomegalovirus infection leads to elevated levels of transplant arteriosclerosis in a humanized mouse aortic xenograft model

American Journal of Transplantation

Volumn 12, Issue 7, 2012, Pages 1720-1729

  Abele Ohl, S ^a   Leis, M ^a   Wollin, M ^a   Mahmoudian, S ^a   Hoffmann, J ^a   Muller R ^a   Heim, C ^a   Spriewald, B M ^a   Weyand, M ^a   Stamminger, T ^a   Ensminger, Stephen M ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Cytomegalovirus; Humanized mouse model; Transplant arteriosclerosis; Xenograft model

Indexed keywords

CD45 ANTIGEN; IMMUNOGLOBULIN M; INTERCELLULAR ADHESION MOLECULE 1; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA GRAFT; ARTERIOSCLEROSIS; ARTICLE; CELL INFILTRATION; CHIMERA; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION RISK; INTERNAL MAMMARY ARTERY; LEUKOCYTE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSPLANT ARTERIOSCLEROSIS; XENOGRAFT;

ANIMALS; ARTERIOSCLEROSIS; CYTOMEGALOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, INBRED C57BL; TRANSPLANTATION;

EID: 84863214238     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04018.x     Document Type: Article

References (42)

1. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-seventh official adult heart transplant report-2010. J Heart Lung Transplant 2010; 29: 1089-1103.
2. Mulligan MS, Shearon TH, Weill D, Pagani FD, Moore J, Murray S. Heart and lung transplantation in the United States, 1997-2006. Am J Transplant 2008; 8(Pt 2): 977-987. (Pubitemid 351389065)
3. Lietz K, Miller LW. Current understanding and management of allograft vasculopathy. Semin Thorac Cardiovasc Surg 2004; 16: 386-394. (Pubitemid 40089671)
4. Weis M, von SW. Coronary artery disease in the transplanted heart. Annu Rev Med 2000; 51: 81-100. (Pubitemid 30216027)
5. Stassen FR, Vega-Cordova X, Vliegen I, Bruggeman CA. Immune activation following cytomegalovirus infection: More important than direct viral effects in cardiovascular disease? J Clin Virol 2006; 35: 349-353. (Pubitemid 43188987)
6. Valantine HA. The role of viruses in cardiac allograft vasculopathy. Am J Transplant 2004; 4: 169-177. (Pubitemid 38248518)
7. Vamvakopoulos J, Hayry P. Cytomegalovirus and transplant arteriopathy: Evidence for a link is mounting, but the jury is still out. Transplantation 2003; 75: 742-743. (Pubitemid 36373440)
8. Potena L, Grigioni F, Magnani G, et al. Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients. J Heart Lung Transplant 2009; 28: 461-467.
9. Potena L, Grigioni F, Magnani G, Branzi A. Prophylaxis versus preemptive therapy for prevention of the consequences of cytomegalovirus infection in transplant recipients: A still unresolved issue. Transplantation 2009; 87: 305-306.
10. Potena L, Holweg CT, Chin C, et al. Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection. Transplantation 2006; 82: 398-405. (Pubitemid 44223041)
11. Bentz GL, Yurochko AD. Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and beta1 and beta3 integrins. Proc Natl Acad Sci U S A 2008; 105: 5531-5536. (Pubitemid 351753897)
12. Kronschnabl M, Stamminger T. Synergistic induction of intercellular adhesion molecule-1 by the human cytomegalovirus transactivators IE2p86 and pp71 is mediated via an Sp1-binding site. J Gen Virol 2003; 84(Pt 1): 61-73. (Pubitemid 36113550)
13. Streblow DN, Soderberg-Naucler C, Vieira J, et al. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 1999; 99: 511-520.
14. Melkus MW, Estes JD, Padgett-Thomas A, et al. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 2006; 12: 1316-1322. (Pubitemid 44706935)
15. Pober JS, Bothwell AL, Lorber MI, McNiff JM, Schechner JS, Tellides G. Immunopathology of human T cell responses to skin, artery and endothelial cell grafts in the human peripheral blood lymphocyte/severe combined immunodeficient mouse. Springer Semin Immunopathol 2003; 25: 167-180.
16. Banuelos SJ, Shultz LD, Greiner DL, et al. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice. Clin Immunol 2004; 112: 273-283. (Pubitemid 39078703)
17. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL. The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 1988; 241: 1632-1639.
18. Lorber MI, Wilson JH, Robert ME, et al. Human allogeneic vascular rejection after arterial transplantation and peripheral lymphoid reconstitution in severe combined immunodeficient mice. Transplantation 1999; 67: 897-903. (Pubitemid 29169137)
19. Abele-Ohl S, Leis M, Mahmoudian S, Weyand M, Stamminger T, Ensminger SM. Rag2-/- gamma-chain-/- mice as hosts for human vessel transplantation and allogeneic human leukocyte reconstitution. Transpl Immunol 2010; 23: 59-64.
20. Hahn G, Khan H, Baldanti F, Koszinowski UH, Revello MG, Gerna G. The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BAC-cloned clinical isolate of human cytomegalovirus with preserved wild-type characteristics. J Virol 2002; 76: 9551-9555. (Pubitemid 34919913)
21. Lorz K, Hofmann H, Berndt A, et al. Deletion of open reading frame UL26 from the human cytomegalovirus genome results in reduced viral growth, which involves impaired stability of viral particles. J Virol 2006; 80: 5423-5434.
22. Tavalai N, Papior P, Rechter S, Stamminger T. Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J Virol 2008; 82: 126-137. (Pubitemid 350309130)
23. Ensminger SM, Billing JS, Morris PJ, Wood KJ. Development of a combined cardiac and aortic transplant model to investigate the development of transplant arteriosclerosis in the mouse. J Heart Lung Transplant 2000; 19: 1039-1046.
24. Hofmann H, Floss S, Stamminger T. Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b. J Virol 2000; 74: 2510-2524. (Pubitemid 30117560)
25. Andreoni M, Faircloth M, Vugler L, Britt WJ. A rapid microneutralization assay for themeasurement of neutralizing antibody reactive with human cytomegalovirus. J Virol Methods 1989; 23: 157-167. (Pubitemid 19069993)
26. Reinhardt B, Vaida B, Voisard R, et al. Human cytomegalovirus infection in human renal arteries in vitro. J Virol Methods 2003; 109: 1-9. (Pubitemid 36349705)
27. Ensminger SM, Spriewald BM, Witzke O, et al. Kinetics of transplant arteriosclerosis in MHC-Class I mismatched and fully allogeneic mouse aortic allografts. Transplantation 2002; 73: 1068-1074. (Pubitemid 34415436)
28. Arbustini E, Dal BB, Morbini P, et al. Factors increasing the risk of allograft vascular disease in heart transplant recipients. G Ital Cardiol 1997; 27: 985-999. (Pubitemid 27452199)
29. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261: 3561-3566. (Pubitemid 19155945)
30. Lemstrom KB, Bruning JH, Bruggeman CA, Lautenschlager IT, Hayry PJ. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts. J Clin Invest 1993; 92: 549-558. (Pubitemid 23262370)
31. Soule JL, Streblow DN, Andoh TF, Kreklywich CN, Orloff SL. Cytomegalovirus accelerates chronic allograft nephropathy in a rat renal transplantmodel with associated provocative chemokine profiles. Transplant Proc 2006; 38: 3214-3220. (Pubitemid 44908561)
32. Streblow DN, Kreklywich C, Yin Q, et al. Cytomegalovirusmediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants. J Virol 2003; 77: 2182-2194. (Pubitemid 36110031)
33. Heim C, Abele-Ohl S, Eckl S, et al. Murine cytomegalovirus infection leads to increased levels of transplant arteriosclerosis in a murine aortic allograft model. Transplantation 2010; 90: 373-379.
34. Fabre JW, Barclay AN, Mason DW. Class II major histocompatibility complex antigens expressed on blood vascular endothelial cells. Transplantation 1983; 36: 597-598.
35. Ferry B, Halttunen J, Leszczynski D, Schellekens H, vd Meide PH, Hayry P. Impact of class II major histocompatibility complex antigen expression on the immunogenic potential of isolated rat vascular endothelial cells. Transplantation 1987; 44: 499-503. (Pubitemid 17154146)
36. Yacoub-Youssef H, Marcheix B, Calise D, et al. Chronic vascular rejection: Histologic comparison between two murine experimental models. Transplant Proc 2005; 37: 2886-2887. (Pubitemid 41354767)
37. Wang Y, Ahmad U, Yi T, et al. Alloimmune-mediated vascular remodeling of human coronary artery grafts in immunodeficient mouse recipients is independent of preexisting atherosclerosis. Transplantation 2007; 83: 1501-1505. (Pubitemid 46934074)
38. Opelz G, Wujciak T. The influence of HLA compatibility on graft survival after heart transplantation. The Collaborative Transplant Study. N Engl J Med 1994; 330: 816-819. (Pubitemid 24083560)
39. Streblow DN, Dumortier J, Moses AV, Orloff SL, Nelson JA. Mechanisms of cytomegalovirus-accelerated vascular disease: Induction of paracrine factors that promote angiogenesis and wound healing. Curr Top Microbiol Immunol 2008; 325: 397-415.
40. Voisard R, Krugers T, Reinhardt B, et al. HCMV-infection in a human arterial organ culture model: Effects on cell proliferation and neointimal hyperplasia. BMC Microbiol 2007; 7: 68-73.
41. Kloover JS, Soots AP, Krogerus LA, et al. Rat cytomegalovirus infection in kidney allograft recipients is associated with increased expression of intracellular adhesion molecule-1 vascular adhesion molecule-1, and their ligands leukocyte function antigen-1 and very late antigen-4 in the graft. Transplantation 2000; 69: 2641-2647. (Pubitemid 30482033)
42. Reinhardt B, Mertens T, Mayr-Beyrle U, et al. HCMV infection of human vascular smooth muscle cells leads to enhanced expression of functionally intact PDGF beta-receptor. Cardiovasc Res 2005; 67: 151-160. (Pubitemid 40798302)